Pharsight

Onmel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8486456 SEBELA IRELAND LTD Itraconazole compositions with improved bioavailability
Oct, 2028

(4 years from now)

Onmel is owned by Sebela Ireland Ltd.

Onmel contains Itraconazole.

Onmel has a total of 1 drug patent out of which 0 drug patents have expired.

Onmel was authorised for market use on 29 April, 2010.

Onmel is available in tablet;oral dosage forms.

Onmel can be used as onychomycosis of the toenail caused by tricophyton rubrum or trichophyton mentagrophytes, once daily use for 12 consecutive weeks.

The generics of Onmel are possible to be released after 03 October, 2028.

Drugs and Companies using ITRACONAZOLE ingredient

Market Authorisation Date: 29 April, 2010

Treatment: Onychomycosis of the toenail caused by tricophyton rubrum or trichophyton mentagrophytes, once daily use for 12 consecutive weeks

Dosage: TABLET;ORAL

More Information on Dosage

ONMEL family patents

Family Patents